Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Patrick C Walsh

Showing results (331-340 of 361) with videos related to

Pageof 37
Sort By:
Cancer Research|March 26, 2009
A novel prostate cancer susceptibility locus at 19q13Fang-Chi Hsu, Jielin Sun, Fredrik Wiklund, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 19, 2010
Inherited genetic variant predisposes to aggressive but not indolent prostate cancerJianfeng Xu, Siqun Lilly Zheng, Sarah D Isaacs, et al.
European Urology Focus|April 7, 2025
Discovery of a Recurrent Frameshift Ashkenazi Jewish Founder Mutation (F722fs) in the PARP Inhibitor-sensitive MMS22L Gene Associated with Higher Risk of Prostate CancerWilliam B Isaacs, Jun Wei, Marta Gielzak, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|August 19, 2007
Prostate cancer. Clinical practice guidelines in oncologyJames Mohler, Richard J Babaian, Robert R Bahnson, et al.
Human Genetics|December 6, 2005
Two-locus genome-wide linkage scan for prostate cancer susceptibility genes with an interaction effectBao-Li Chang, Ethan M Lange, Latchezar Dimitrov, et al.
Journal of the National Cancer Institute|October 11, 2007
Association between two unlinked loci at 8q24 and prostate cancer risk among European AmericansS Lilly Zheng, Jielin Sun, Yu Cheng, et al.
The New England Journal of Medicine|January 13, 2012
Germline mutations in HOXB13 and prostate-cancer riskCharles M Ewing, Anna M Ray, Ethan M Lange, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|February 10, 2010
NCCN clinical practice guidelines in oncology: prostate cancerJames Mohler, Robert R Bahnson, Barry Boston, et al.
Cancer Research|March 1, 2005
A germline DNA polymorphism enhances alternative splicing of the KLF6 tumor suppressor gene and is associated with increased prostate cancer riskGoutham Narla, Analisa Difeo, Helen L Reeves, et al.
Journal of the National Cancer Institute|December 13, 2007
Two genome-wide association studies of aggressive prostate cancer implicate putative prostate tumor suppressor gene DAB2IPDavid Duggan, Siqun L Zheng, Michele Knowlton, et al.
Pageof 37

Showing results (331-340 of 361) with videos related to

Sort By:
Pageof 37
Cancer Research|March 26, 2009
A novel prostate cancer susceptibility locus at 19q13Fang-Chi Hsu, Jielin Sun, Fredrik Wiklund, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 19, 2010
Inherited genetic variant predisposes to aggressive but not indolent prostate cancerJianfeng Xu, Siqun Lilly Zheng, Sarah D Isaacs, et al.
European Urology Focus|April 7, 2025
Discovery of a Recurrent Frameshift Ashkenazi Jewish Founder Mutation (F722fs) in the PARP Inhibitor-sensitive MMS22L Gene Associated with Higher Risk of Prostate CancerWilliam B Isaacs, Jun Wei, Marta Gielzak, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|August 19, 2007
Prostate cancer. Clinical practice guidelines in oncologyJames Mohler, Richard J Babaian, Robert R Bahnson, et al.
Human Genetics|December 6, 2005
Two-locus genome-wide linkage scan for prostate cancer susceptibility genes with an interaction effectBao-Li Chang, Ethan M Lange, Latchezar Dimitrov, et al.
Journal of the National Cancer Institute|October 11, 2007
Association between two unlinked loci at 8q24 and prostate cancer risk among European AmericansS Lilly Zheng, Jielin Sun, Yu Cheng, et al.
The New England Journal of Medicine|January 13, 2012
Germline mutations in HOXB13 and prostate-cancer riskCharles M Ewing, Anna M Ray, Ethan M Lange, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|February 10, 2010
NCCN clinical practice guidelines in oncology: prostate cancerJames Mohler, Robert R Bahnson, Barry Boston, et al.
Cancer Research|March 1, 2005
A germline DNA polymorphism enhances alternative splicing of the KLF6 tumor suppressor gene and is associated with increased prostate cancer riskGoutham Narla, Analisa Difeo, Helen L Reeves, et al.
Journal of the National Cancer Institute|December 13, 2007
Two genome-wide association studies of aggressive prostate cancer implicate putative prostate tumor suppressor gene DAB2IPDavid Duggan, Siqun L Zheng, Michele Knowlton, et al.
Pageof 37